Home > Compound List > Product Information
Budesonide_Molecular_structure_CAS_51333-22-3)
Click picture or here to close

Budesonide

Catalog No. PHR1178 Name Sigma Aldrich
CAS Number 51333-22-3 Website http://www.sigmaaldrich.com
M. F. C25H34O6 Telephone 1-800-521-8956
M. W. 430.53386 Fax
Purity Email
Storage Chembase ID: 132753

SYNONYMS

IUPAC name
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
IUPAC Traditional name
budesonide
Synonyms
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione

DATABASE IDS

MDL Number MFCD00083259
EC Number 257-139-7
CAS Number 51333-22-3

PROPERTIES

Empirical Formula (Hill Notation) C25H34O6
Grade certified reference material
Packaging pkg of 500 mg
Pharmacopeia Traceability traceable to BP 793
Pharmacopeia Traceability traceable to PhEur B1157300
Pharmacopeia Traceability traceable to USP 1078201
MSDS Link Download
German water hazard class 3

DETAILS

Description (简体中文)
General description
This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO Guide 34.
Other Notes
Values of analytes vary lot to lot.
Biochem/physiol Actions
Budesonide is a second generation glucocorticoid with low systemic absorption. It is used as an anti-inflammatory agent in the treatment of asthma, rhinitis, and inflammatory bowel disease. It inhibits the expression of chemokine mRNA and production of eotaxin and RANTES protein in primary human bronchial epithelial cells. Budesonide is currently in clinical trials for the prevention of lung cancer. It shows inhibitory effects on benzo[a]pyrene-induced carcinogenesis of the lung in mice.
Description (English)
General description
This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO Guide 34.
Other Notes
Values of analytes vary lot to lot.
Biochem/physiol Actions
Budesonide is a second generation glucocorticoid with low systemic absorption. It is used as an anti-inflammatory agent in the treatment of asthma, rhinitis, and inflammatory bowel disease. It inhibits the expression of chemokine mRNA and production of eotaxin and RANTES protein in primary human bronchial epithelial cells. Budesonide is currently in clinical trials for the prevention of lung cancer. It shows inhibitory effects on benzo[a]pyrene-induced carcinogenesis of the lung in mice.

REFERENCES